Cost effectiveness and strategic planning (WHO-CHOICE)

AFR E: Cost effectiveness results for HIV/AIDS

This Table provides summary results of the total population-level costs, effects and cost-effectiveness for the selected WHO sub-region and risk factor / disease for the year 2000.

KEY
I$ - International Dollars
Program Costs include costs of administration, media, training etc
Patient Costs include costs of hospital visits, drugs, etc
Incremental cost-effectiveness ratio (ICER) is defined as the incremental change in cost, divided by the incremental change in effectiveness. ICERs are reported for the successive set of interventions that would be selected at expanding levels of resource availability, starting with the intervention with the lowest cost per DALY averted, then moving to the next most cost-effective combination intervention out of the remaining available set of interventions.
Dominated is used to denote an intervention that is more costly and/or less effective than other, more efficient (single or combined) interventions; i.e. dominated interventions do not appear on the expansion path of most cost-effective strategies.


Interventions:Codes_and_Descriptions Coverage Cost per year (I$, millions) per one million_population [i.e. cost per capita] % Program costs % Patient costs DALYs averted per year per one million_population Average Cost per DALY averted Incremental Cost per DALY averted
HIV-1 : Peer education for sex workers [EDS] (50% coverage) 50% 0.12 26,555 4 Dominated
HIV-2 : Peer education for sex workers [EDS] (80% coverage) 80% 0.18 41,318 4 Dominated
HIV-3 : Peer education for sex workers [EDS] (95% coverage) 95% 0.20 48,357 4 Dominated
HIV-4 : Combination: EDS + provision of treatment for STI (50% coverage) 50% 0.12 33,476 4 Dominated
HIV-5 : Combination: EDS + provision of treatment for STI (80% coverage) 80% 0.18 50,653 4 Dominated
HIV-6 : Combination: EDS + provision of treatment for STI (95% coverage) 95% 0.21 58,452 4 Dominated
HIV-7 : Mass media [MED] (100%) 100% 0.05 13,140 3 3
HIV-8 : School-based education [SDE] (50% coverage) 50% 0.17 316 530 Dominated
HIV-9 : School-based education [SDE] (80% coverage) 80% 0.22 502 444 Dominated
HIV-10 : School-based education [SDE] (95% coverage) 95% 0.22 594 376 Dominated
HIV-11 : Treatment of sexually-transmitted infections [STI] (current coverage) 0.12 6,529 19 Dominated
HIV-12 : Treatment of sexually-transmitted infections [STI] (enhanced coverage) 0.32 15,720 21 Dominated
HIV-13 : Treatment of sexually-transmitted infections [STI] (95 % coverage) 0.66 20,664 32 Dominated
HIV-14 : Voluntary counseling & testing [VCT] at 95% coverage 1.18 14,414 82 Dominated
HIV-15 : Prevention of Mother-to-Child-Transmission (PMTCT) 0.47 13,617 34 Dominated
HIV-16 : Highly Active Anti-Retroviral Therapy (HAART), simple 3.91 7,028 556 Dominated
HIV-17 : HAART (simple) + Directly Observed Treatment Strategy (DOTS) for TB 4.36 7,316 596 Dominated
HIV-18 : HAART Plus (interleukin 2) 18.62 9,266 2,010 Dominated
HIV-19 : HAART Plus + DOTS for TB 20.10 10,169 1,977 Dominated
HIV-20: Combination: MED + EDS50 0.16 38,695 4 Dominated
HIV-21: Combination: MED + EDS80 0.22 52,834 4 Dominated
HIV-22: Combination: MED + EDS95 0.25 59,559 4 Dominated
HIV-23: Combination: MED + EDS-STI50 0.17 45,178 4 4
HIV-24: Combination: MED + EDS-STI80 0.23 61,521 4 4
HIV-25: Combination: MED + EDS-STI95 0.26 68,932 4 4
HIV-26: Combination: EDS-STI95 + STIcurrent 0.33 60,470 5 Dominated
HIV-27: Combination: EDS-STI95 + STIenhanced 0.53 63,283 8 Dominated
HIV-28: Combination: EDS-STI95 + STI95% 0.86 64,787 13 Dominated
HIV-29: Combination: MED + EDS-STI95 + STIcurrent 0.38 70,754 5 Dominated
HIV-30: Combination: MED + EDS-STI95 + STIenhanced 0.57 73,296 8 Dominated
HIV-31: Combination: MED + EDS-STI95 + STI95% 0.91 74,655 12 Dominated
HIV-32: Combination: MED + EDS-STI95 + STI95% + PMTCT 1.37 84,426 16 Dominated
HIV-33: Combination: MED + EDS-STI95 + STI95% + PMTCT + SBE50 1.54 84,627 18 Dominated
HIV-34: Combination: MED + EDS-STI95 + STI95% + PMTCT + SBE80 1.60 84,746 19 Dominated
HIV-35: Combination: MED + EDS-STI95 + STI95% + PMTCT + SBE95 1.60 84,805 19 Dominated
HIV-36: Combination: MED + EDS-STI95 + STI95% + PMTCT + SBE95 + VCT 2.71 89,721 30 Dominated
HIV-37: Combination: MED + EDS-STI95 + STI95% + PMTCT + SBE95 + VCT + HAARTSimpNoDOTS 6.37 96,410 66 631
HIV-38: Combination: MED + EDS-STI95 + STI95% + PMTCT + SBE95 + VCT + HAARTSimpDOTS 6.80 96,784 70 1,144
HIV-39: Combination: MED + EDS-STI95 + STI95% + PMTCT + SBE95 + VCT + HAARTPlusNoDOTS 20.23 98,747 205 Dominated
HIV-40: Combination: MED + EDS-STI95 + STI95% + PMTCT + SBE95 + VCT + HAARTPlusDOTS 21.66 99,655 217 5,175
HIV-41: Combination: MED + EDS-STI95 + STI95% + PMTCT + SBE95 + HAARTSimpNoDOTS 5.28 91,559 58 Dominated
HIV-42: Combination: MED + EDS-STI95 + STI95% + PMTCT + SBE95 + HAARTSimpDOTS 5.71 91,933 62 Dominated
HIV-43: Combination: MED + EDS-STI95 + STI95% + PMTCT + SBE95 + HAARTPlusNoDOTS 19.21 93,924 204 Dominated
HIV-44: Combination: MED + EDS-STI95 + STI95% + PMTCT + SBE95 + HAARTPlusDOTS 20.63 94,843 218 Dominated
HIV-45: Combination: MED + EDS-STI95 +STI95% + PMTCT + HAARTSimpNoDOTS 5.06 91,195 55 Dominated
HIV-46: Combination: MED + EDS-STI95 + STI95% + PMTCT + HAARTSimpDOTS 5.49 91,569 60 Dominated
HIV-47: Combination: MED + EDS-STI95 + STI95% + PMTCT + HAARTPlusNoDOTS 18.99 93,563 203 Dominated
HIV-48: Combination: MED + EDS-STI95 + STI95% + PMTCT + HAARTPlusDOTS 20.42 94,482 216 Dominated
HIV-49: Combination: MED + EDS-STI95 + STI95% + PMTCT + VCT + HAARTSimpNoDOTS 6.15 96,058 64 547
HIV-50: Combination: MED + EDS-STI95 + STI95% + PMTCT + VCT + HAARTSimpDOTS 6.58 96,432 68 Dominated
HIV-51: Combination: MED + EDS-STI95 + STI95% + PMTCT + VCT + HAARTPlusNoDOTS 20.02 98,398 203 Dominated
HIV-52: Combination: MED + EDS-STI95 + STI95% + PMTCT + VCT + HAARTPlusDOTS 21.44 99,307 216 Dominated
HIV-53: Combination: MED + EDS-STI95 + STI95%  HAARTSimpNoDOTS 4.60 81,628 56 Dominated
HIV-54: Combination: MED + EDS-STI95 + STI95%  HAARTSimpDOTS 5.03 82,004 61 Dominated
HIV-55: Combination: MED + EDS-STI95 + STI95%  HAARTPlusNoDOTS 18.54 84,024 221 Dominated
HIV-56: Combination: MED + EDS-STI95 + STI95%  HAARTPlusDOTS 19.97 84,959 235 Dominated
HIV-57: Combination: MED + EDS-STI95 + PMTCT 0.72 78,978 9 46
HIV-58: Combination: MED + EDS-STI95 + PMTCT + STIcurrent 0.84 80,713 10 68
HIV-59: Combination: MED + EDS-STI95 + PMTCT + STIenhanced 1.03 83,132 12 80
HIV-60: Combination: MED + STIenhanced 0.37 27,839 13 Dominated
HIV-61: Combination: MED + STI95% 0.71 32,429 22 Dominated
HIV-62: Combination: MED + STIcurrent 0.17 19,264 9 Dominated
HIV-63: Combination: MED + EDS-STI95 + PMTCT + STI95% 1.37 84,426 16 Dominated
HIV-64: Combination: MED + EDS-STI95 + PMTCT + STI95% + VCT 2.49 89,354 28 290
HIV-65: Combination: MED + EDS-STI95 + VCT 1.38 74,716 18 Dominated
HIV-66: Combination: MED + EDS-STI95 + VCT + STIcurrent 1.49 76,353 20 Dominated
HIV-67: Combination: MED + EDS-STI95 + VCT + STIenhanced 1.68 78,638 21 Dominated
HIV-68: Combination: MED + EDS-STI95 + VCT + STI-95% 2.02 79,861 25 Dominated
HIV-69: Combination: MED + EDS-STI95 + VCT + STIcurrent + PMTCT 1.96 86,010 23 Dominated
HIV-70: Combination: MED + EDS-STI95 + VCT + STIenhanced + PMTCT 2.15 88,188 24 220
HIV-71: Combination: MED + EDS-STI95 + VCT + PMTCT 1.84 84,450 22 Dominated
HIV-72: Combination: MED + EDS-STI95 + STI95% + VCT + HAARTSimpNoDOTS 5.69 86,766 66 Dominated
HIV-73: Combination: MED + EDS-STI95 + STI95% + VCT + HAARTSimpDOTS 6.12 87,141 70 Dominated
HIV-74: Combination: MED + EDS-STI95 + STI95% + VCT + HAARTPlusNoDOTS 19.57 89,132 220 Dominated
HIV-75: Combination: MED + EDS-STI95 + STI95% + VCT + HAARTPlusDOTS 21.00 90,056 233 Dominated
HIV-76: Combination: MED + EDS-STI95 + SBE95 0.48 69,360 7 Dominated
HIV-77: Combination: MED + EDS-STI95 + STIcurrent + SBE95 0.60 71,172 8 Dominated
HIV-78: Combination: MED + EDS-STI95 + STIenhanced + SBE95 0.79 73,700 11 Dominated
HIV-79: Combination: MED + EDS-STI95 + STI95 + SBE95 1.13 75,052 15 Dominated
HIV-80: Combination: MED + EDS-STI95 + STIcurrent + SBE95 + VCT 1.72 76,757 22 Dominated
HIV-81: Combination: MED + EDS-STI95 + STIenhanced + SBE95 + VCT 1.91 79,029 24 Dominated
HIV-82: Combination: MED + EDS-STI95 + STI95 + SBE95 + VCT 2.25 80,245 28 Dominated
HIV-83: Combination: MED + EDS-STI95 + STIcurrent + SBE95 + PMTCT 1.06 81,112 13 Dominated
HIV-84: Combination: MED + EDS-STI95 + STIenhanced + SBE95 + PMTCT 1.26 83,518 15 Dominated
HIV-85: Combination: MED + EDS-STI95 + STI95 + SBE95 + PMTCT 1.60 84,805 19 Dominated
HIV-86: Combination: MED + EDS-STI95 + PMTCT + VCT + HAARTSimpNoDOTS 5.51 91,158 60 Dominated
HIV-87: Combination: MED + EDS-STI95 + PMTCT + VCT + HAARTSimpNoDOTS + STIcurrent 5.63 92,717 61 Dominated
HIV-88: Combination: MED + EDS-STI95 + PMTCT + VCT + HAARTSimpNoDOTS + STIenhanced 5.81 94,894 61 Dominated
HIV-89: Combination: MED + EDS-STI95 + STIenhanced + SBE95 + VCT + PMTCT 2.37 88,561 27 Dominated
HIV-90: Combination: MED + EDS-STI95 + PMTCT + VCT + HAARTSimpNoDOTS + STI95 6.15 96,058 64 Dominated
HIV-91: Combination: MED + EDS-STI95 + PMTCT + VCT + HAARTSimpNoDOTS + STIenhanced + SBE95 6.04 95,252 63 Dominated
Share